Impax Defeats FTC Pay-For-Delay Complaint, Helped By Status As Sole Marketer Of Generic Opana ER

 
• By Brenda Sandburg
Man Controlling Trade statue in front of the Federal Trade Commission Building

More from Generics

More from Biosimilars & Generics